Skip to main content
  • ALL-HEART: Allopurinol Does Not Improve CV Outcomes in Ischemic Heart Disease Patients without Gout

    A 600-mg daily dose of allopurinol did not improve cardiovascular outcomes compared with standard care in patients older than 60 years of age with ischemic heart disease but no history of gout, new trial results show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details